Halofuginone: a potent inhibitor of critical steps in angiogenesis progression.
about
Prevention of intra-abdominal adhesions using the antiangiogenic COX-2 inhibitor celecoxibNewly generated heparanase knock-out mice unravel co-regulation of heparanase and matrix metalloproteinasesHalofuginone inhibits the establishment and progression of melanoma bone metastases.Anti-angiogenic effects of pterogynidine alkaloid isolated from Alchornea glandulosa.New molecular medicine-based scar management strategiesHalofuginone enhances the radiation sensitivity of human tumor cell linesTh17 cells and IL-17 in protective immunity to vaginal candidiasis.Microarray profiling reveals the integrated stress response is activated by halofuginone in mammary epithelial cells.Halofuginone has anti-proliferative effects in acute promyelocytic leukemia by modulating the transforming growth factor beta signaling pathway.Diminished corneal angiogenesis in gelatinase A-deficient mice.Phase II AIDS Malignancy Consortium trial of topical halofuginone in AIDS-related Kaposi sarcoma.Halofuginone suppresses the lung metastasis of chemically induced hepatocellular carcinoma in rats through MMP inhibition.Halofuginone inhibits angiogenesis and growth in implanted metastatic rat brain tumor model--an MRI studyHalofuginone inhibits multiple myeloma growth in vitro and in vivo and enhances cytotoxicity of conventional and novel agents.Halofuginone inhibits phosphorylation of SMAD-2 reducing angiogenesis and leukemia burden in an acute promyelocytic leukemia mouse model.Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastasesSurgical stress resistance induced by single amino acid deprivation requires Gcn2 in mice.Treatment of pediatric brain tumors.Halofuginone attenuates osteoarthritis by inhibition of TGF-β activity and H-type vessel formation in subchondral bone.Plant-derived anticancer agents: a promising treatment for bone metastasis.Pharmacological management of Kaposi's sarcoma.Halofuginone - the multifaceted molecule.The integrated stress response.DTD, an anti-inflammatory ditriazine, inhibits angiogenesis in vitro and in vivoHalofuginone inhibition of COL1A2 promoter activity via a c-Jun-dependent mechanism.Expression of MMP, HPSE, and FAP in stroma promoted corneal neovascularization induced by different etiological factors.Growth inhibition of prostate cancer xenografts by halofuginone.Anti-angiogenic properties of carnosol and carnosic acid, two major dietary compounds from rosemary.The preventive effect of halofuginone on posterior glottic stenosis in a rabbit model.Suppression of VEGF-induced angiogenesis and tumor growth by Eugenia jambolana, Musa paradisiaca, and Coccinia indica extracts.The effect of antifibrotic drug halofugine on Th17 cells in concanavalin A-induced liver fibrosis.Halofuginone Attenuates Osteoarthritis by Rescuing Bone Remodeling in Subchondral Bone Through Oral Gavage.Halofuginone prevents subglottic stenosis in a canine model.COL1A1: A potential therapeutic target for colorectal cancer expressing wild-type or mutant KRAS
P2860
Q24540362-973AADE5-A71C-4E52-82E2-3D9B5A9A4B69Q28475274-6AD75E36-4DC3-4CF8-82B7-0D77F80481A5Q30393926-F095F3BF-1D3B-47BD-B642-3ECED02F5D84Q33450973-0967B95A-FBB7-4073-87F1-482F69A28CFEQ33560989-3CDCD609-45C5-44B3-9A53-AFE631DB76F7Q33717031-3C560C2B-1B4E-4CFC-AA53-08172A2CB0D1Q33983438-FBC106F5-86BE-4AA2-832E-755FDFBF61CDQ34040933-C5F9C2F0-F878-439E-A5C2-5B55480F394FQ34067009-ADFF4DE3-E606-48EA-8737-58230B404996Q34102769-AA5E1B09-FE58-41A5-8F33-5B6A98D3B467Q34472886-BD3121E3-70C9-49CF-86E7-FA691EEB352EQ35081499-5FE2E467-7CDC-4FBD-B4D8-200785B570A0Q35127962-DDF722DC-B51D-4BB0-8732-85FAFAF0A0BAQ35552714-8130EEA5-965C-453D-9BA9-70AC0613456CQ35800540-C2959B5F-C34E-4CB2-9901-718F5AB47E4AQ35987375-7D267A5F-6D05-4980-86AD-E94A17555B9FQ36503034-E73C7B1F-38D8-46C1-A104-6E3D6D776646Q36953476-64D85182-76D0-4A49-86C2-42790A7881D3Q37235742-EDDDB8C8-BBE7-434B-B032-C327EC6B776BQ37640924-73573C9B-DC1F-4E4B-8C60-F9A5DA1A4297Q37868566-3CE2A08F-FBAE-444D-9E40-569D3B50E29BQ38311322-CFF23232-787F-4854-9C2D-FDC7C536FF1DQ38954583-3A63E33D-55C6-4CFD-A7FD-BE58778AA1ADQ39941554-D86D4106-0B29-444F-92D0-7CF6C7D25763Q42526981-9E3AD4C4-5269-49B0-A2FD-118DFDC9180DQ42854407-C5A1D02D-9F8C-476B-AAA1-21CC2ED4DFCCQ43956506-4B2A6858-9E4E-4561-9749-426ED01BA6FAQ44461904-A7C720A6-7BF2-4043-BC0A-D9390AA58AD1Q46514225-0C8D4D2C-94A0-4699-B5D5-8AAFC8AA0A98Q50757266-D81CA4A0-1D30-41AC-B6F5-E6055DD382FFQ51761921-B50B2854-6126-48AD-897F-665B7F94FC78Q52595224-81166052-CEBE-431C-9E77-4C8FFAA1C93EQ53620186-E251E714-23D8-4201-A3A4-F282516C71DFQ58716665-76B8A0C1-37CA-4B21-A14A-5722B16E5082
P2860
Halofuginone: a potent inhibitor of critical steps in angiogenesis progression.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Halofuginone: a potent inhibitor of critical steps in angiogenesis progression.
@en
Halofuginone: a potent inhibitor of critical steps in angiogenesis progression.
@nl
type
label
Halofuginone: a potent inhibitor of critical steps in angiogenesis progression.
@en
Halofuginone: a potent inhibitor of critical steps in angiogenesis progression.
@nl
prefLabel
Halofuginone: a potent inhibitor of critical steps in angiogenesis progression.
@en
Halofuginone: a potent inhibitor of critical steps in angiogenesis progression.
@nl
P2093
P356
P1433
P1476
Halofuginone: a potent inhibitor of critical steps in angiogenesis progression.
@en
P2093
Vlodavsky I
P304
P356
10.1096/FJ.00-0292COM
P407
P577
2000-12-01T00:00:00Z